The United States has a $115.5 billion trade deficit in pharmaceutical products, which the Trump administration has suggested it may try to equalize through tariffs.

Major drug companies are beginning to deliver their first-quarter readouts to Wall Street analysts, revealing their expectations of how a global tariff war could affect their bottom lines.

Here’s what several large drugmakers said about tariffs when reporting earnings this morning: Merck made a small downward adjustme